<< USPTO issues patent to NJIT's unique device for treatment of brain injury | Researchers identify gene required for proper development of mouse inner ear >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Avedro's Lasik Xtra procedure receives CE Approval

Published on January 4, 2012 at 2:12 AM · No Comments

Avedro, Inc. announced today that the Company's proprietary Lasik Xtra procedure has received CE Approval. Lasik Xtra is a two minute procedure used in conjunction with standard Lasik to restore the biomechanical integrity and strength to the cornea after a Lasik procedure. Lasik Xtra has been successfully used in thousands of Lasik surgeries outside the US.

"Cross-linking within a LASIK procedure using Lasik Xtra is simple, fast and safe," said A. John Kanellopoulos, MD, a leading refractive surgeon and member of Avedro's Medical Advisory Board. "In studies we'll be reporting at ASCRS in April we've found that after almost two years of follow-up, hyperopes appear to have a completely different clinical course if we employ prophylactic cross-linking in their LASIK procedures. Hyperopic LASIK typically regresses more than myopic LASIK."

Lasik Xtra combines VibeX™ (riboflavin ophthalmic solution) with its KXL™ System (UVA irradiation) to achieve accelerated corneal cross-linking during a Lasik procedure. "Avedro has the only cross-linking products specifically CE approved for performing Lasik Xtra and we are pleased to offer those products to a growing number of ophthalmologists and their Lasik patients outside the US," said David Muller, CEO of Avedro.

Source: Avedro, Inc.

Posted in: Device / Technology News | Medical Procedure News

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading